Takeda Pharmaceutical Company Limited (TAK) Financials

TAK Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 96.3 billion 49.8 billion
March 31, 2026 97.2 billion 48.3 billion
Dec. 31, 2025 98.4 billion 49.6 billion
Sept. 30, 2025 97.8 billion 49.6 billion

TAK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 453.8 million 111.8 million
March 31, 2026 63.5 million 123.4 million
Dec. 31, 2025 963.1 million 113.6 million
Sept. 30, 2025 2.2 billion 126.6 million

TAK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 696.0 million
March 31, 2026 -2.3 billion
Dec. 31, 2025 662.2 million
Sept. 30, 2025 -79.2 million

TAK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.2 billion 27.2 billion -
March 31, 2026 3.7 billion 27.5 billion -
Dec. 31, 2025 4.9 billion 27.3 billion -
Sept. 30, 2025 5.0 billion 29.4 billion -

TAK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 19.7 million
March 31, 2026 19.6 million
Dec. 31, 2025 20.5 million
Sept. 30, 2025 21.3 million

TAK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 330.9 million 1.0 billion 1.8 billion -
March 31, 2026 403.1 million 1.2 billion 1.9 billion -
Dec. 31, 2025 1.4 billion 1.1 billion 1.8 billion -
Sept. 30, 2025 356.9 million 1.1 billion 1.7 billion -

TAK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.5 billion 2.5 billion
March 31, 2026 7.0 billion 3.6 billion
Dec. 31, 2025 7.7 billion 3.5 billion
Sept. 30, 2025 7.5 billion 2.6 billion

TAK

Price: $17.86

52 week price:
12.99
19.05

Dividend Yield: 3.42%

5-year range yield:
3.33%
5.08%

Forward Dividend Yield: 3.45%

Payout Ratio: 177.09%

Payout Ratio Range:
-1840.96%
1893.98%

Dividend Per Share: 0.62 USD

Earnings Per Share: -0.33 USD

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Japan

Volume: 2.3 million

Market Capitalization: 58.7 billion

Average Dividend Frequency: 2

Years Paying Dividends: 19

DGR3: -2.55%

DGR5: -3.99%

DGR10: -5.34%

Links: